Position in KRYS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,717,279
+$855,309 QoQ
Shares Held
7,311
+1.4% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#143
of 419 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 66%
Shared 0%
None 34%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARTINGALE ASSET MANAGEMENT L P holds $144,833,314 across 62 Biotechnology names. KRYS ranks #13 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
42,729 | $21,224,776 | |
| 2 | INCY |
Incyte Corp
|
168,818 | $19,137,208 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
59,492 | $14,335,787 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,953 | $11,817,953 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
17,562 | $5,551,172 | |
| 6 | ACAD |
Acadia Pharmaceuticals Inc
|
167,893 | $4,247,692 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,634 | $4,104,243 | |
| 8 | INVA |
Innoviva, Inc.
|
165,115 | $3,749,761 |
All Filings in KRYS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,717,279 | 7,311 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,861,970 | 7,208 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,110,909 | 4,506 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $795,267 | 4,505 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $619,257 | 4,505 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $926,020 | 5,136 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $804,604 | 5,136 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $934,723 | 5,135 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $942,991 | 5,135 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,038,042 | 5,834 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,449,888 | 11,687 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,364,972 | 11,767 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,416,783 | 12,068 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,089,456 | 13,608 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,078,025 | 13,608 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $320,829 | 4,603 | Shares | Sole | 2022-11-14 | |
| 2021-09-30 | $699,927 | 13,406 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $442,408 | 6,506 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $508,926 | 6,606 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $402,360 | 6,706 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,481,178 | 34,406 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,377,715 | 57,405 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $1,072,352 | 24,800 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||